\n<\/p>\n
22nd Century Group is also helping New Zealand become less tobacco-dependent<\/em><\/p>\n New York-based 22nd Century Group, Inc. (XXII) is known for developing plant-based solutions for research purposes as well as consumer markets.<\/p>\n In its own way, 22nd Century has made significant contributions to the cannabis market, while helping some consumers to reduce their nicotine and tobacco usage.<\/p>\n This is a small company, but it\u2019s teaming up with a couple of the biggest names in the global cannabis industry. Just that news, by itself, could propel XXII stock to new heights in 2022.<\/p>\n On top of that, it\u2019s just been revealed that 22nd Century is supporting one particular government\u2019s efforts to reduce tobacco consumption. Truly, this company is prepared to promote the population\u2019s health while building its brand and assuring value for all stakeholders.<\/p>\n A Closer Look at XXII Stock<\/strong><\/p>\n From a technical standpoint, you couldn\u2019t have picked a better time to get on board with XXII stock.<\/p>\n As of mid-December, the stock was trading right at the bottom of its defined range in 2021. We\u2019ve seen it in the past, as XXII stock is capable of moving from $2 to $5.50 very quickly.<\/p>\n If you can catch XXII stock anywhere near $2 or even $3, you can employ a buy-low, sell-higher strategy. Plus, this stock is affordable for practically any investment account size, so that\u2019s a big advantage.<\/p>\n XXII stock might establish a new range in 2022, so you might have to adjust your strategy when the time is right. At the moment, however, it certainly appears that the stock is much closer to the bottom than the top.<\/p>\n Partnering with Cannabis Giants<\/strong><\/p>\n In a development that could be a real game changer, 22nd Century Group revealed that it\u2019s collaborating with not just one, but two large and well-known cannabis companies.<\/p>\n